Inge W. Verberk

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Plasma Alzheimer Biomarkers and Diagnostic Decision-Making in Memory Clinics.

Plasma Alzheimer Biomarkers and Diagnostic Decision-Making in Memory Clinics.

Journal: JAMA network open

Published: August 13, 2026

Agreement between clinical diagnosis and blood biomarkers of Alzheimer's disease in a real-world peripheral memory clinic.

Agreement between clinical diagnosis and blood biomarkers of Alzheimer's disease in a real-world peripheral memory clinic.

Journal: Journal of Alzheimer's disease : JAD

Published: July 28, 2026

Amateur Soccer Heading and Acute Elevations in Blood-Based p-Tau217 and S100B.

Amateur Soccer Heading and Acute Elevations in Blood-Based p-Tau217 and S100B.

Journal: JAMA neurology

Published: May 18, 2026

Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals.

Glial Fibrillary Acidic Protein and Neurofilament Light Reference Intervals in Healthy Individuals.

Journal: JAMA network open

Published: May 14, 2026

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

The potential of key Alzheimer's plasma biomarkers to mimic tau PET MUBADA-based disease staging.

Journal: Alzheimer's research & therapy

Published: February 11, 2026

Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury.

Serum NfL, GFAP, and p-tau217 in adults with drug-resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury.

Journal: Epilepsia

Published: December 23, 2025

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.

Longitudinal Blood-Based Biomarkers and Clinical Progression in Subjective Cognitive Decline.

Journal: JAMA network open

Published: December 03, 2025

An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.

An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration.

Journal: Nature medicine

Published: November 18, 2025

Clinical performance of scalable automated p-tau 217 multi-analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay.

Clinical performance of scalable automated p-tau 217 multi-analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: September 26, 2025

Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly.

Individualized prediction of clinical progression to dementia using plasma biomarkers in non-demented elderly.

Journal: Alzheimer's research & therapy

Published: September 15, 2025

Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.

Cerebrospinal Fluid Amyloid and Tau Biomarker Changes Across the Alzheimer Disease Clinical Spectrum.

Journal: JAMA network open

Published: July 10, 2025

Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium.

Evidence-based standardized sample handling protocol for accurate blood-based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 04, 2025

Showing 1-12 of 78

Last Updated: 09/26/2026